AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
EPS Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-12.4%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-12.4%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202510.45%
202464.59%
2023-27.21%
2022-50.36%
202187.50%
202020.32%
2019-2.42%
20185.16%
201713.44%
201628.41%